New York Health Welcomes Jay B. Adlersberg, M.D

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Dr. Jay B. Adlersberg. (Courtesy photo)

New York Health recently announced that Dr. Jay B. Adlersberg, a rheumatologist and internist, has joined the team.

Adlersberg has 45 years of experience treating the most severe forms of arthritis and joint disease. His main interests are rheumatoid arthritis, the arthritis of psoriasis, back pain and autoimmune disorders. His expertise is in the use of biologic drugs to treat severe arthritis. He serves on the Board of the New York Chapter of the Arthritis Foundation. Adlersberg is already known to millions of tristate residents as the nightly medical reporter for WABC-TV’s Eyewitness News, a job he did for 30 years while continuing to practice medicine.

Adlersberg was educated at the University of Pittsburgh, where he graduated junior year Phi Beta Kappa and magna cum laude. He graduated from the University of Pennsylvania School of Medicine, the nation’s oldest medical school and one of its most prestigious. He completed a coveted residency at the country’s most respected city hospital and training ground for clinical medicine, the Bellevue Hospital Center of NYU Langone Medical Center in New York. Adlersberg did his fellowship in Rheumatology and Immunology as an NIH-Postdoctoral Fellow at the Irvington House Institute of NYU Medical Center under the guidance of the late Edward C. Franklin, M.D., a world-renowned immunologist and member of the National Academy of Sciences.

“One of the advantages of practicing at New York Health,” said Adlersberg, “is doing patient infusions right across the hallway, instead of in a center ten blocks away. Now, I have immediate access to a patient having a problem or a drug reaction.“

To reach Dr. Jay B. Adlersberg, call 212-324-3334. For more information, visit www.NYHealth.com.

—Submitted by NY Health

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Never miss any important news. Subscribe to our newsletter.

Leave a Reply

Never miss any important news. Subscribe to our newsletter.

Recent News

Editor's Pick

x